As pharmaceutical companies race to develop treatments for metabolic dysfunction–associated steatohepatitis (MASH) and related steatotic liver disease (SLD), one critical piece of the healthcare puzzle is drawing increasing attention: how to diagnose and monitor millions of patients at scale. … Continue reading →

A group of emerging small-cap companies across robotics, critical minerals, healthcare technology, oncology therapeutics, and blockchain-based finance are drawing increased attention from investors searching for “AI robotics stocks,” “critical minerals supply chain companies,” “micro-cap medtech innovations,” “oncology biotech pipeline companies,” … Continue reading →